Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $699.65 | 37 | 98.5% |
| Education | $10.40 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $368.94 | 22 | $0 (2020) |
| Amgen Inc. | $131.89 | 5 | $0 (2020) |
| GlaxoSmithKline, LLC. | $53.10 | 3 | $0 (2019) |
| Lilly USA, LLC | $49.90 | 3 | $0 (2023) |
| Novo Nordisk Inc | $45.46 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.31 | 1 | $0 (2018) |
| Amarin Pharma Inc. | $19.60 | 1 | $0 (2020) |
| Arbor Pharmaceuticals, Inc. | $14.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.29 | 1 | Lilly USA, LLC ($13.29) |
| 2020 | $59.38 | 3 | Amgen Inc. ($28.59) |
| 2019 | $125.51 | 7 | AstraZeneca Pharmaceuticals LP ($33.23) |
| 2018 | $311.03 | 16 | AstraZeneca Pharmaceuticals LP ($195.51) |
| 2017 | $200.84 | 12 | AstraZeneca Pharmaceuticals LP ($129.01) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/26/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Neuroscience | ||||||
| 08/05/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiovascular | ||||||
| 01/30/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Neuroscience | ||||||
| 12/12/2019 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Diabetes | ||||||
| 10/31/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Diabetes | ||||||
| 04/25/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 03/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Bone Health | ||||||
| 01/28/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: Neuroscience | ||||||
| 11/15/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 08/09/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Respiratory | ||||||
| 05/01/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: DIABETES | ||||||
| 04/18/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Cardiology | ||||||
| 02/22/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 408 | 955 | $106,077 | $50,011 |
| 2022 | 3 | 463 | 1,044 | $113,202 | $53,932 |
| 2021 | 4 | 537 | 1,158 | $122,811 | $60,042 |
| 2020 | 4 | 546 | 1,128 | $117,235 | $46,298 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 282 | 827 | $102,115 | $46,653 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 64 | $2,091 | $2,049 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 63 | 64 | $1,872 | $1,309 | 69.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 293 | 874 | $107,939 | $49,508 | 45.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 85 | 85 | $2,777 | $2,722 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 85 | 85 | $2,486 | $1,703 | 68.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 309 | 930 | $114,798 | $55,759 | 48.6% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 105 | 105 | $2,997 | $2,089 | 69.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 105 | 105 | $3,430 | $1,985 | 57.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 18 | 18 | $1,586 | $208.80 | 13.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 312 | 890 | $109,861 | $41,941 | 38.2% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 108 | 110 | $2,191 | $2,101 | 95.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 108 | 110 | $3,594 | $2,015 | 56.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 18 | 18 | $1,590 | $241.34 | 15.2% |
About Dr. Ron Teramoto, MD
Dr. Ron Teramoto, MD is a Internal Medicine healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801997895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ron Teramoto, MD has received a total of $710.05 in payments from pharmaceutical and medical device companies, with $13.29 received in 2023. These payments were reported across 39 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($699.65).
As a Medicare-enrolled provider, Teramoto has provided services to 1,954 Medicare beneficiaries, totaling 4,285 services with total Medicare billing of $210,283. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Aiea, HI
- Active Since 09/25/2006
- Last Updated 10/16/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801997895
Products in Payments
- BYDUREON (Drug) $190.75
- FARXIGA (Drug) $132.38
- Aimovig (Biological) $58.63
- Prolia (Biological) $46.58
- TRULICITY (Drug) $36.61
- BREO (Drug) $33.14
- Repatha (Biological) $26.68
- JARDIANCE (Drug) $26.31
- SYMBICORT (Drug) $24.75
- BEVESPI AEROSPHERE (Drug) $21.06
- ANORO (Drug) $19.96
- Vascepa (Drug) $19.60
- Tresiba (Drug) $16.19
- Victoza (Drug) $15.59
- Edarbi (Drug) $14.85
- Ozempic (Drug) $13.68
- EMGALITY (Drug) $13.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aiea
Roy Ebisu, Md, MD
Internal Medicine — Payments: $18,765
Stephen Miyasato, Md, MD
Internal Medicine — Payments: $18,084
Dr. Francis Buto, M.d, M.D
Internal Medicine — Payments: $14,868
Dr. Alan Oki, Md, MD
Internal Medicine — Payments: $14,573
Mark Nishihara, M.d, M.D
Internal Medicine — Payments: $14,206
Dr. Malissa Iida-Takashima, Md, MD
Internal Medicine — Payments: $13,761